Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: A&G PHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-05-26 to 2022-05-25
Current total value of award: $40945.03
Description: GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST PTH-IA.